Profile of risk factors for stroke: sex- and age-related differences
Authors/Creators
- 1. Department of Neurology, Medical University of Silesia Hospital No. 7, Upper Silesian Medical Centre, Katowice, Poland School of Health Science, Medical University of Silesia, Katowice, Poland
Description
Lasek-Bal Anetta. Profile of risk factors for stroke: sex- and age-related differences. Journal of Health Sciences. 2014;4(15):19-28. ISSN 1429-9623 / 2300-665X.
http://ojs.ukw.edu.pl/index.php/johs/article/view/2014%3B4%2815%29%3A19-28
http://journal.rsw.edu.pl/index.php/JHS/article/view/2014%3B4%2815%29%3A19-28
https://pbn.nauka.gov.pl/works/513212
DOI: 10.5281/zenodo.13376
http://dx.doi.org/10.5281/zenodo.13376
The journal has had 5 points in Ministry of Science and Higher Education of Poland parametric evaluation. Part B item 1107. (17.12.2013).
© The Author (s) 2014;
This article is published with open access at Licensee Open Journal Systems of Radom University in Radom, Poland
Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License
(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.
This is an open access article licensed under the terms of the Creative Commons Attribution Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non commercial
use, distribution and reproduction in any medium, provided the work is properly cited.
Conflict of interest: None declared. Received: 15.11.2014. Revised 05.12.2014. Accepted: 10.12.2014.
Profile of risk factors for stroke: sex- and age-related differences
Anetta Lasek-Bal
Department of Neurology, Medical University of Silesia Hospital No. 7, Upper Silesian Medical Centre, Katowice, Poland
School of Health Science, Medical University of Silesia, Katowice, Poland
Keywords: risk factor, stoke, gender.
Abstract
The objective of the study was to compare the incidence of key risk factors of stroke in men and women with first-ever stroke.
Material and methods: The study included 511 patients ( F/M 304/207 aged 32-100 years with stroke. The incidence of the following diseases was analyzed: arterial hypertension, lipid disorders, coronary artery disease, atrial fibrillation, diabetes mellitus, carotid and/or cerebral artery stenosis and age of the occurrence of stroke.
Results: The age at which first-ever stroke occurred was higher in women (p<0.001). Atrial fibrillation occurred significantly more frequently in women in comparison with men , particular among patients >55 years old. Among patients ≤ age of 55, men suffered significantly more often from arterial hypertension, lipid disorders , coronary artery disease and diabetes . Among patients > 55, lipid disorders and diabetes occurred significantly more frequently in women . Age had significant effect on the incidence of HA (OR=3.46,CI 1.69-7.07, p=0.0006), CAD (OR=3.40,CI 1.69-6.84, p=0.0006), AF (OR=2.73,CI 1.13-6.62, p=0.025), DM (OR=2.29,CI 1.16-4.53, p=0.016). Among men, there was a higher proportion of patients with carotid/cerebral artery stenosis (p=0,0065) and among women; there were also more patients with cardiogenic stroke (p=0,0014).
Conclusions:
There are sex-dependent differences in the incidence of key risk factors of stroke.
Women more frequently suffer from cardiogenic stroke and men more often from stroke associated with artery diseases.
The lower incidence of cardiovascular system diseases and metabolic disorders in young women can be the reason for the older age at which first-ever stroke occurs.
Notes
Files
2014_4_15_19-28_2490_966.pdf
Additional details
Related works
References
- 1. Fukuda M, Kanda T, Kamide N et al. Gender differences in long-term functional outcome after first-ever ischemic stroke.Intern Med. 2009;48(12):967-973.
- 2. Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35-41.
- 3. Amarenco P, Bogousslavsky J, Caplan LR et al. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke.CerebrovascDis. 2009;27(5):502-508.
- 4. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke.Stroke. 2003 Jul;34(7):1581-1585.
- 5. Förster A, Gass A, Kern Ret al. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009 Jul;40(7):2428-2432.
- 6. Zivin JA, Fisher M, DeGirolami Uet al. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science. 1985 Dec 13;230(4731):1289-1292.
- 7. Hill MD, Kent DM, Hinchey Jet al. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke. 2006 Sep;37(9):2322-2325.
- 8. Niessen F, Hilger T, Hoehn M, Hossmann KA.. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke. 2003 Aug;34(8):2019-2024.
- 9. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke. 2000 Aug;31(8):1833-1837.
- 10. Di Carlo A, Lamassa M, Baldereschi Met al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry.Stroke. 2003 May;34(5):1114-1119.
- 11. Labiche LA, Chan W, Saldin KR, Morgenstern LB. Sex and acute stroke presentation. Ann Emerg Med. 2002Nov;40(5):453-460.
- 12. Kolominsky-Rabas PL, Weber M, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001 Dec 1;32(12):2735-2740.
- 13. Glader EL, Stegmayr B, Norrving Bet al. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003 Aug;34(8):1970-1975.
- 14. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun;45(6):613-619.
- 15. Stuart-Shor EM, Wellenius GA, DelloIacono DM, Mittleman MA. Gender differences in presenting and prodromal stroke symptoms.Stroke. 2009 Apr;40(4):1121-1126.
- 16. Smith DB, Murphy P, Santos Pet al.. Gender differences in the Colorado Stroke Registry. Stroke. 2009 Apr;40(4):1078-1081.
- 17. Appelros P, Stegmayr B, Terént A. Sex differences in strokeepidemiology: a systematic review. Stroke. 2009 Apr;40(4):1082-1090.
- 18. Roquer J, Campello AR, Gomis M. Stroke.Sex differences in first-ever acute stroke. Stroke 2003 Jul;34(7):1581-1585.
- 19. Morikawa Y, Nakagawa H, Naruse Yet al. Trends in stroke incidence and acute case fatality in a Japanese rural area: the Oyabe study. Stroke. 2000; 31: 1583–1587.
- 20. Vibo R, Kôrv J, Roose M. The Third Stroke Registry in Tartu, Estonia: decline of stroke incidence and 28-day case-fatality rate since 1991. Stroke. 2005; 36: 2544–2548.
- 21. Terént A. Trends in stroke incidence and 10-year survival in Söderhamn, Sweden, 1975–2001. Stroke. 2003; 34: 1353–1358.
- 22. Viscoli CM, Brass LM, Kernan WN et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001 Oct 25;345(17):1243-1249.
- 23. Rossouw JE, Prentice RL, Manson JE et al. Postmenopausalhormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007 Apr 4;297(13):1465-1477. Erratum in: JAMA. 2008 Mar 26;299(12):1426.
- 24. Hendrix SL, Wassertheil-Smoller S, Johnson KC et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.Circulation. 2006 May 23;113(20):2425-2434.
- 25. Gorelick PB, Ruland S. Cerebral vascular disease.Dis Mon. 2010 Feb;56(2):39-41.
- 26. Worrall BB, Johnston KC, Kongableet al. Stroke risk factor profiles in African American women: an interim report from the African-American Antiplatelet Stroke Prevention Study. Stroke. 2002; 33: 913–919.
- 27. Giroud M, Milan C, Beuriat P et al. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989.Int J Epidemiol. 1991 Dec;20(4):892-899.
- 28. Hays SN, Taler SJ. Hypertension in women current understanding of gender differences. Mayo ClinProc 1998; 73: 157-165.
- 29. Di Angelantonio E, Gao P, Pennells L et al. Lipid-related markers and cardiovascular disease prediction.JAMA. 2012 Jun 20;307(23):2499-506.
- 30. Rosendorff C. Statins for prevention of stroke. Lancet. 1998 Apr 4;351(9108):1002-1003.
- 31. Larry B. Goldstein LB, Amarenco P et al. Relative Effects of Statin Therapy on Stroke and Cardiovascular Events in Men and Women. Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke. 2008; 39: 2444-2448.
- 32. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22: 983-988.
- 33. Furberg CD, Psaty BM, Manolio T, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994; 74: 236-241.
- 34. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370-2375.
- 35. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002; 113: 359–364.
- 36. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003; 290: 1049–1056.
- 37. Friberg J, Scharling H, Gadsbøll Net al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol. 2004; 94: 889–894.
- 38. Humphries KH, Kerr CR, Connolly SJ et al. New-onsetatrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation. 2001 May 15;103(19):2365-2370.
- 39. Simons L, Simons J, Friedlander Y et al. A comparison of risk factors for coronary heart disease and ischaemic stroke: the Dubbp study of Australian elderly. Hear Lung Circ 2009; 18: 330-333.
- 40. Fox K, Ford I, Steg PG et all. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.Lancet. 2008 Sep 6;372(9641):817-821.
- 41. Ortega-Casarrubios MA, Fuentes B, San José B et al. Influence of previous diagnosis of diabetes mellitus in the stroke severity and in-hospital outcome in acute cerebral infarction.Neurologia. 2007 Sep;22(7):426-433.
- 42. Reeves MJ, Bushnell CD, Howard G. et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008 Oct;7(10):915-926.
- 43. Roquer J, Rodríguez Campello A, Gomis M et al. Sex Differences in First-Ever Acute Stroke. Stroke. 2003; 34: 1581-1585.
- 44. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke. A population perspective. Diabetologia. 1995 Sep;38(9):1061-1068.
- 45. Alkayed NJ, Harukuni I, Kimes AS et al. Gender-linked brain injury in experimental stroke. Stroke. 1998;29:159–165.
- 46. McCullough LD, Alkayed NJ, Traystman RJ et al. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke. 2001;32:796–802.
- 47. Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function. J ApplPhysiol. 2006;101:1252–61.
- 48. McCullough LD, Hurn PD. Estrogen and ischemic neuroprotection: an integrated view. TrendsEndocrinolMetab. 2003;14:228–235.
- 49. Kuy S, Seabrook GR, Rossi PJ et al. Management of carotid stenosis in women. JAMA Surg. 2013 Aug;148(8):788-790.
- 50. Chun LJ, Tsai J, Tam M et al. Screening carotid artery duplex in patients undergoing cardiac surgery. Ann Vasc Surg. 2013 Nov 5.
- 51. Huxley RR, Bell EJ, Lutsey PL et al. A comparative analysis of risk factors for stroke in blacks and whites: the Atherosclerosis Risk in Communities study. Ethn Health. 201 Béjot Y, Daubail B, Jacquin A et al. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry. J Neurol Neurosurg Psychiatry. 2013 Nov 18. doi: 10.1136/jnnp-2013-306203.
- 52. Supanc V, Sonicki Z, Vukasovic I et al. The Role of Classic Risk Factors and Prothrombotic Factor Gene Mutations in Ischemic Stroke Risk Development in Young and Middle-Aged Individuals. J Stroke Cerebrovasc Dis. 2013 Nov 1. pii: S1052-3057(13)00399-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.025.
- 53. Béjot Y, Daubail B, Giroud M. Epidemiology and prognosis of stroke in young adults. Rev Prat. 2013 Sep;63(7):926-929.
- 54. Béjot Y, Daubail B, Jacquin A et al. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry. J Neurol Neurosurg Psychiatry. 2013 Nov 18. doi: 10.1136/jnnp-2013-306203.